Sort by
Refine Your Search
-
Listed
-
Employer
- ;
- KINGS COLLEGE LONDON
- Nature Careers
- King's College London
- University of Birmingham
- UNIVERSITY OF MELBOURNE
- University of Cambridge
- University of Nottingham
- ; Technical University of Denmark
- ; University of Kent
- CRANFIELD UNIVERSITY
- QUEENS UNIVERSITY BELFAST
- Queen's University Belfast
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- UNIVERSITY OF SOUTHAMPTON
- University College London
- University of Glasgow
- University of London
- 8 more »
- « less
-
Field
-
will be educated to doctoral level in remote sensing, agricultural engineering, geospatial science, bioinformatics (or similar relevant subject) and have research experience in plant science. With
-
, covering areas from neuroscience and biochemistry to zoology and bioinformatics. Our neuroscience research spans multiple levels—from genes and molecules to behaviour and cognition. Visit the School of Life
-
by computational/bioinformatics members of the team. Chimaera studies will be in partnership with our collaborator Ramiro Alberio at the University of Nottingham. About you Postdoctoral Research
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported
-
models with a key focus on integrating pathology, radiology, and electronic health records (EHRs), while collaborating with the bioinformatics team to incorporate molecular data such as bulk RNA-Seq, whole
-
models with a key focus on integrating pathology, radiology, and electronic health records (EHRs), while collaborating with the bioinformatics team to incorporate molecular data such as bulk RNA-Seq, whole
-
culture, cellular transfection, RNA expression analysis (qRT-PCR, RNA-seq), FACS analysis, Western blotting, ELISA, and bioinformatics. A background or interest in osteoarthritis, drug discovery, RNA
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported
-
, neuroimaging, neurophysiology, proteomics, transcriptomics, epigenomics, metabolomics, bioinformatics, cell models and animal models. First in man and Phase 2, 3 and 4 clinical trials are also strongly supported
-
to evaluate and validate naïve pluripotency. Transcriptomics and network inference will be supported by computational/bioinformatics members of the team. Chimaera studies will be in partnership with our